NIFTY 5024,318.00 0.62%
SENSEX80,142.00 0.48%
GOLD /10G72,410.00— stable
10Y G-SEC6.94— stable
USD/INR83.42 0.06%
NIFTY 5024,318.00 0.62%
SENSEX80,142.00 0.48%
GOLD /10G72,410.00— stable
10Y G-SEC6.94— stable
USD/INR83.42 0.06%
Swayam Financial Services

Market News & Updates

Stay informed with useful updates from markets, mutual funds, and investor awareness initiatives.

Why investors should not ignore largecaps despite the smallcap rush: Canara Robeco CIO Shridatta Bhandwaldar

25 Aug 2026

Why investors should not ignore largecaps despite the smallcap rush: Canara Robeco CIO Shridatta Bhandwaldar

We are looking at the next 12-18 months from a two perspective, corporate earnings growth and impact of geopolitics through higher energy prices on the Indian market. From the corporate earnings perspective we are fairly constructive. After 1.5 years of earnings downcycle, the earnings cycle has been reviving from 2HFY26.

Read More
Sensex drops 200 points, Nifty falls below 24,150 as US announces harsher sanctions against Iran. What lies ahead?

25 Aug 2026

Sensex drops 200 points, Nifty falls below 24,150 as US announces harsher sanctions against Iran. What lies ahead?

Indian equities extended losses on Tuesday, with Sensex falling 200 points to below 77,150 and Nifty declining 83 points to 24,136. HCL Tech and Tech Mahindra led losses, while Trent gained. Metal and IT stocks weakened, though market breadth turned positive. Analysts see Nifty rangebound, with support at 24,150 and resistance at 24,500.

Read More
Sumax Engineering SME IPO opens today; GMP signals 32% listing gain

25 Aug 2026

Sumax Engineering SME IPO opens today; GMP signals 32% listing gain

The Sumax Engineering IPO opened for subscription on August 25, 2026, on the NSE SME platform and will remain open until August 28. With a grey market premium of Rs 32, the issue indicates a potential 32% listing gain.

Read More
Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?

25 Aug 2026

Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?

Symbiotec Pharmalab IPO enters its second day with 80% subscription and a 34% GMP, indicating strong listing expectations. The Rs 1,757 crore issue offers specialised API and biotechnology exposure, while proceeds will reduce debt. However, premium valuations and moderate return ratios warrant careful consideration despite strong investor interest.

Read More
Tempsens Instruments allotment today; GMP signals 105% listing gains. Here’s how to check your status

25 Aug 2026

Tempsens Instruments allotment today; GMP signals 105% listing gains. Here’s how to check your status

Tempsens Instruments IPO allotment is expected on August 25 after the Rs 650-crore issue was subscribed 184.07 times. Investors can check their allotment status through the registrar’s website, NSE or BSE. With the IPO’s GMP indicating a potential 105% premium, the stock is expected to attract strong interest ahead of its August 28 listing.

Read More
Dixon Technologies among 4 F&O stocks with sharp OI jump

25 Aug 2026

Dixon Technologies among 4 F&O stocks with sharp OI jump

A significant uptick in futures open interest indicates a substantial increase in the number of active, unexpired futures contracts in a particular security.

Read More
← PreviousPage 6 of 6